RhumbLine Advisers’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-81,740
| Closed | -$2.25M | – | 3049 |
|
|
2021
Q2 | $2.25M | Buy |
81,740
+6,513
| +9% | +$179K | ﹤0.01% | 1895 |
|
|
2021
Q1 | $1.24M | Sell |
75,227
-5,315
| -7% | -$87.6K | ﹤0.01% | 2113 |
|
|
2020
Q4 | $1.48M | Buy |
80,542
+10,311
| +15% | +$190K | ﹤0.01% | 1982 |
|
|
2020
Q3 | $956K | Buy |
70,231
+1,478
| +2% | +$20.1K | ﹤0.01% | 2010 |
|
|
2020
Q2 | $1.23M | Buy |
68,753
+27,470
| +67% | +$492K | ﹤0.01% | 1956 |
|
|
2020
Q1 | $412K | Buy |
41,283
+2,761
| +7% | +$27.6K | ﹤0.01% | 2255 |
|
|
2019
Q4 | $314K | Buy |
38,522
+1,413
| +4% | +$11.5K | ﹤0.01% | 2570 |
|
|
2019
Q3 | $368K | Sell |
37,109
-240
| -0.6% | -$2.38K | ﹤0.01% | 2470 |
|
|
2019
Q2 | $472K | Buy |
37,349
+5,637
| +18% | +$71.2K | ﹤0.01% | 2386 |
|
|
2019
Q1 | $323K | Buy |
31,712
+21,397
| +207% | +$218K | ﹤0.01% | 2503 |
|
|
2018
Q4 | $77K | Buy |
+10,315
| New | +$77K | ﹤0.01% | 2908 |
|